Producer
Borealis AG
Borealis AG (Vienna Austria; majority owned by OMV AG, the Austrian state-controlled energy company; ~€10B revenue) is Europe's leading specialty polyolefin producer and the dominant supplier of medical-grade and meltblown-grade PP resins for European hygiene and filtration markets. Borealis' Borflow series (HL504FB, HF955MO) are the most widely specified meltblown PP grades in Europe, with MFR of 800-1,500 g/10min and ISO 10993 biocompatibility certification for medical device applications. Borealis produces meltblown-grade PP at its Schwechat Austria site (adjacent to OMV's Schwechat refinery) and its Porvoo Finland site. Borealis' Borflow grades command premium pricing (15-30% over commodity PP) due to their medical certification, fiber consistency, and low extractables — making them preferred for N95 respirators and hospital filtration media. Borealis was majority-acquired by OMV to ~75% stake in 2020-2022 for €4.1B.
2
Inputs supplied
2
Goods downstream
1
Facilities
0
Stories
What they make
2 inputs Borealis AG supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Borealis AG makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Medical & Filtration PP (Bormed/Borflow)
25%Polyolefin Base Chemicals
45%Fertilizers & Base Chemicals
20%Infrastructure Pipeline Materials
10%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Concentration2023
Borealis AG's Schwechat Austria facility is the sole ISO 10993-certified medical-grade meltblown PP production site in Continental Europe. ISO 10993 (Biological Evaluation of Medical Devices) certification requires extensive biocompatibility testing — cytotoxicity, sensitization, genotoxicity — conducted on the specific resin from a specific plant with a specific catalyst lot. Meltblown PP from an alternative European supplier (e.g., LyondellBasell Rotterdam) cannot be substituted into medical device applications without repeating the full ISO 10993 test series, which takes 12-24 months and costs €200,000-€500,000 per resin grade. This means that during a supply disruption at Borealis Schwechat, European N95 manufacturers face a choice between ceasing production or using non-medically-certified PP — a regulatory violation in EU MDR-compliant markets. A single Austrian plant determines whether European medical N95 production can continue.
Borealis AG ↗Did you know2023
Borealis AG (Vienna) is 75% owned by OMV — Austria's state-linked oil and gas company — with the remaining 25% held by Mubadala Investment Company, the sovereign wealth fund of Abu Dhabi. This means the medical-grade polypropylene that becomes the film in European IV bags is majority-owned by the Austrian state oil company and partly owned by the Abu Dhabi sovereign wealth fund. The supply chain of Fresenius Kabi freeflex IV bags runs: Austrian oil company → Borealis cracker (Austrian/Belgian/Finnish) → Bormed PP resin → Wipak coextrusion (Finland) → pharmaceutical film → freeflex IV bag → European hospital. A hospital IV bag involves an Austrian national oil company and a Gulf sovereign wealth fund before it reaches a patient.
Borealis AG ↗Origin2023
Borealis was founded in 1994 as a joint venture between OMV (Austria's state energy company) and Statoil (Norway's state energy company) to combine their polyolefin (polypropylene and polyethylene) production capabilities. The merger brought together OMV's Austrian cracker operations (integrated with OMV's Schwechat refinery, which converts crude oil to olefin feedstocks) and Statoil's Nordic polymer technology. Borealis developed the Borstar process -- a proprietary bimodal polyolefin polymerization technology -- that enabled production of PE with broader molecular weight distribution for demanding applications like gas pipe and medical films. Statoil sold its Borealis stake in 1998; Mubadala (Abu Dhabi) acquired a 25% stake in 2008. OMV increased its stake to 75% in 2022 for €4.1B, making Borealis 75% Austrian state energy company and 25% Abu Dhabi sovereign wealth. The company that produces the sole ISO 10993-certified medical-grade meltblown PP in Continental Europe is owned by Austria's national oil company and Abu Dhabi's government investment fund -- two entities with no conventional connection to hospital supply chains.
Borealis AG ↗